Exodus Point Capital Management, LP Design Therapeutics, Inc. Transaction History

Exodus Point Capital Management, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	BUY	$4.99 - $7.64 $545,137 - $834,639	109,246 Added 69.97%	265,384 $1.67 Million
Q1 2023 May 11, 2023	BUY	$5.5 - $9.77 $579,738 - $1.03 Million	105,407 Added 207.78%	156,138 $901,000
Q4 2022 Feb 13, 2023	SELL	$7.86 - $17.2 $8,724 - $19,092	-1,110 Reduced 2.14%	50,731 $521,000
Q3 2022 Nov 10, 2022	BUY	$14.09 - $25.57 $730,439 - $1.33 Million	51,841 New	51,841 $867,000

102

31M

2.3K

16.5K

Ticker DSGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,807,900
Market Cap $252M
Description
Design Therapeutics, Inc. a preclinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of genetic diseases caused by nucleotide repeat expansions. The company's portfolio of products comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ syste...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.